2011年我国对瑞士的中药贸易额为1832.8万美元，同比下降14.82%，双方贸易的主要部分是我国对瑞士的提取物出口。受世界经济环境严峻、企业成本增加和汇率等因素的影响，2012年1~4月我国与瑞士的中药贸易额同比呈现进一步下降趋势。

In 2011, the traditional Chinese medicine trade to Switzerland for $18.328 million，14.82% year-on-year drop，Both sides of the main parts in China is trade of Switzerland extract exports。By the world economic environment severe、Enterprise cost increase and exchange rate factors，2012 1 ~ 4 months of traditional Chinese medicine trade between China and the Swiss year-on-year decline on further。

　　中药在瑞士的应用主要有三种方式：中药饮片制成的汤药。中成药：国内原装中成药不允许在瑞士出售，但可以按配方配制，使用较多。配方成品中药，即国内的免煎中药，以浸膏粉和滴剂为主，被广泛使用。

The application of traditional Chinese medicine in Switzerland mainly have three ways：Chinese medicine yinpian herb tea made of。Proprietary Chinese medicine：Domestic original proprietary Chinese medicine not allowed to sell in Switzerland，But can press formula，Use more。Formula finished product Chinese medicine，That is the domestic from Fried Chinese traditional medicine，To extract powder and drop agent mainly，Was widely used。

　　瑞士在中药饮片、中成药的进口与使用上，有严格限制。中药不能够以药品名义进入，只能以特殊食品、食品补充剂、保健品或饮料名义进口销售。每批中药进口都要按品种检测其毒性、农药残留、重金属含量等，无论进货量大小，每种都要付出较高的检测费。

The Swiss in Chinese medicine yinpian、The import and use of traditional Chinese medicine，restrictions。Traditional Chinese medicine can't name medicine into，Only with special food、Food supplements、Health care products or beverage name import sales。Each batch of traditional Chinese medicine imported by its toxicity testing varieties、Pesticide residues、Heavy metal content, etc，No matter the size is simply illustrated，Each will pay higher detect cost。

　　我国中成药出口瑞士数量很小，尤其自去年欧盟传统医药注册指令生效以后，我国中药出口欧盟出现萎缩，瑞士虽不是欧盟国家，但也受此影响，出口更是大幅下滑。

Traditional Chinese medicine in China export Switzerland is a very small number，Especially since last year the European Union of traditional medicine registration instructions after effect，Traditional Chinese medicine in China export the eu appear to atrophy，Switzerland is not the countries of the European Union，But also affected by this，Exports are the decline。

　　2012年1~4月我国对瑞士中药出口企业共有26家，其中民营企业为16家，出口16.58万美元，同比下降69%,占全部企业对瑞士中药出口额的5%；中外合资企业为3家，出口136万美元，同比增长3684.6%,占全部企业对瑞士中药出口额的41.2%；外商独资企业为3家，出口170万美元，同比下降60%,占全部企业对瑞士中药出口额的51.3%；国有企业为4家，出口8.2万美元，同比增长10.7%,占全部企业对瑞士中药出口额的2.5%。

2012 1 ~ 4 months of traditional Chinese medicine in China Swiss export enterprise, there are 26 house，Private enterprises of sixteen，Export $165800，69% year-on-year drop,Of all the enterprise to Switzerland exports 5% of traditional Chinese medicine；Sino-foreign joint venture enterprise for three，Export $1.36 million，Year-on-year growth of 3684.6%,Of all the enterprise to Switzerland exports 41.2% of traditional Chinese medicine；A wholly foreign owned enterprise for three，Export $1.7 million，60% year-on-year drop,Of all the enterprise to Switzerland exports 51.3% of traditional Chinese medicine；The state-owned enterprise for four，Export $82000，Year-on-year growth of 10.7%,Of all the enterprise to Switzerland exports 2.5% of traditional Chinese medicine。

　　瑞士的医疗卫生和社会保险体系非常发达，作为一个高工资、高福利的国家，瑞士在医药卫生方面的开支相对很高，且近年来一直持续上升。瑞士人口老龄化严重，从整个社会的情况来看，多数老年人生活优裕富足，因此，除一般的治疗性药物外，对各类保健性药物有着长期稳定的需求。

Swiss health and social insurance system is developed，As a high salary、Gao fuli country，The Swiss in medicine and health spending relatively high，And in recent years has continued to rise。Swiss population aging serious，From the whole social situation，Most old people good living rich，so，In addition to the general therapeutic drugs outside，Health care for all kinds of chiral drugs have long-term stable demand。

　　瑞士人口数量较少，市场容量十分有限，对药品注册与进口有着严格的规定。近年来，由于化学药发展所遇到的困难，瑞士开始重视传统医药的应用。但受现行医药管理法规管理的限制，中医药在瑞士的发展仍然存在诸多困难，所以中药在瑞士注册的难度和之后的市场收益，是企业判断是否值得为中药注册投入时间与金钱的前提。

Swiss population less，The market size is very limited，Drug registration and imported to have strict regulations。In recent years，Chemical medicine development due to the difficulties，The Swiss are paying attention to the application of traditional medicine。But the current medical management regulations management limited，The development of Chinese medicine in Switzerland still exists many problems，So the difficulty of traditional Chinese medicine in Switzerland registered and after market returns，Is the enterprise determine whether for Chinese traditional medicine is registered in the premise of time and money。